These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7988953)
21. [Perioperative intervention to prevent lower extremity deep venous thrombosis after gynecologic surgery]. Zhu ZJ; Fang SH; Wang MZ; Lou HY; Shu J; Ying KJ Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):669-72. PubMed ID: 20079178 [TBL] [Abstract][Full Text] [Related]
22. Postoperative prophylaxis of venous thromboembolism (VTE) in patients undergoing high ligation and stripping of the great saphenous vein (GSV). Wang H; Sun Z; Jiang W; Zhang Y; Li X; Wu Y Vasc Med; 2015 Apr; 20(2):117-21. PubMed ID: 25601917 [TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement. Mätzsch T; Bergqvist D; Fredin H; Hedner U Acta Chir Scand Suppl; 1988; 543():80-4. PubMed ID: 2461017 [TBL] [Abstract][Full Text] [Related]
24. Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement. Mätzsch T; Bergqvist D; Fredin H; Hedner U Acta Chir Scand; 1990; 156(6-7):445-50. PubMed ID: 1695053 [TBL] [Abstract][Full Text] [Related]
25. Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin. Welzel D; Wolf H; Koppenhagen K Arzneimittelforschung; 1988 Jan; 38(1):120-3. PubMed ID: 2835055 [TBL] [Abstract][Full Text] [Related]
26. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery. Beghi C; Fragnito C; Antonelli A; Reverberi C; Ferrari P; Saccani S; Fesani F Int Angiol; 1993 Dec; 12(4):383-6. PubMed ID: 8207317 [TBL] [Abstract][Full Text] [Related]
27. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity. Sue-Ling HM; Davies JA; Prentice CR; Verheijen JH; Kluft C Thromb Haemost; 1985 Feb; 53(1):141-2. PubMed ID: 3873118 [TBL] [Abstract][Full Text] [Related]
28. [Role of low molecular weight heparin in the prevention of postoperative deep venous thrombosis. Our experience in 88 cases]. Verardi S; Cortese F; Baroni B; Boffo V; Casciani CU G Chir; 1989 Nov; 10(11):674-8. PubMed ID: 2562010 [TBL] [Abstract][Full Text] [Related]
29. [Prevention of thrombosis with low molecular weight heparin in gynecology]. Villena-Heinsen C; Schmidt W Zentralbl Gynakol; 1995; 117(6):289-92. PubMed ID: 7645354 [TBL] [Abstract][Full Text] [Related]
30. The influence of LMW heparin on the coagulation and fibrinolytic response to surgery. Melissari E; Scully MF; Paes T; Kakkar VV Thromb Res; 1985 Jan; 37(1):115-26. PubMed ID: 3920775 [TBL] [Abstract][Full Text] [Related]
31. [A comparison of low dose heparin and oral anticoagulants in the prevention ot thrombo-phlebitis following gynaecological operations (author's transl)]. Baertschi U; Schaer A; Bader P; Huber L; Morf P Geburtshilfe Frauenheilkd; 1975 Oct; 35(10):754-60. PubMed ID: 1183792 [TBL] [Abstract][Full Text] [Related]
32. [Defibrotide versus heparin in antithrombotic prophylaxis in gynecological surgery]. Lippi G; Viliani T; Alessandrello-Liotta A; Morelli P; Zucconi G; Doni A; Gerosa C Minerva Med; 1989 May; 80(5):455-9. PubMed ID: 2664571 [TBL] [Abstract][Full Text] [Related]
33. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216). Marassi A; Balzano G; Mari G; D'Angelo SV; Della Valle P; Di Carlo V; D'Angelo A Int Surg; 1993; 78(2):166-70. PubMed ID: 8394842 [TBL] [Abstract][Full Text] [Related]
34. A double-blind trial of intramuscular stanozolol in the prevention of postoperative deep vein thrombosis following elective abdominal surgery. Blamey SL; McArdle BM; Burns P; Carter DC; Lowe GD; Forbes CD Thromb Haemost; 1984 Feb; 51(1):71-4. PubMed ID: 6539002 [TBL] [Abstract][Full Text] [Related]
35. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II]. Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523 [TBL] [Abstract][Full Text] [Related]
36. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis. Páramo JA; Alfaro MJ; Rocha E Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269 [TBL] [Abstract][Full Text] [Related]
37. Prevention of postoperative deep vein thrombosis by two different heparin types. Catania G; Salanitri G Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):304-9. PubMed ID: 2842266 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity. España F; Hendl S; Gilabert J; Estellés A; Aznar J Thromb Res; 1993 Jun; 70(5):375-84. PubMed ID: 8397450 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of hemostatic and fibrinolytic alterations associated with daily administration of low-molecular-weight heparin for a 12-week period. Lojewski B; Bacher P; Iqbal O; Walenga JM; Hoppensteadt D; Leya F; Fareed J Semin Thromb Hemost; 1995; 21(2):228-39. PubMed ID: 7660145 [TBL] [Abstract][Full Text] [Related]
40. Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery. Speziale F; Verardi S; Taurino M; Nicolini G; Rizzo L; Fiorani P; Palazzini E Pharmatherapeutica; 1988; 5(4):261-8. PubMed ID: 3174726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]